What You Should Know:
- A large majority of physicians feel GLP-1s are being overprescribed, according to a new survey from Virta Health, a leader in type 2 diabetes reversal.
- The Virta Health survey was conducted in partnership with Beresford Research and included 300 primary care providers, endocrinologists, and obesity specialists across the United States sheds light on the medical community's views on the rapidly growing class of GLP-1 medications, often hailed as
Read More
Diabetes Prevention Platform
9am.health, Ascensia Partner to Expand Virtual Diabetes Clinic
What You Should Know:
- 9am.health today announced it is expanding its virtual diabetes clinic through a strategic partnership with Ascensia to add the CONTOUR®NEXT ONE Blood Glucose Meter to Its patient toolkit.
- 9am.health patients can now conveniently add Ascensia Diabetes Care’s blood glucose meter and test strips to their personalized treatment plan, with the meter offered free of charge to all patient care plans. The test strip add-on is available through a
Read More
Humana Taps Vida Health to Power Virtual Diabetes Management for Kentucky’s Medicaid Population
What You Should Know:
- Humana Healthy Horizons™ in Kentucky announced it has selected Vida Health’s virtual diabetes management program to serve Kentucky’s Medicaid population.
- Vida’s diabetes management program
achieves lasting results for participants. Because chronic conditions like diabetes,
obesity, and hypertension often occur simultaneously, Vida’s unique program was
built from the ground up to treat multiple conditions at the same time.
- The new partnership, which will
Read More
Virta Adds Prediabetes and Obesity Reversal to Services
What You Should Know:
- Virta is expanding its suite of treatment options to
include prediabetes reversal, obesity reversal, and type 2 diabetes management.
- By making this crucial expansion, Virta can scale its
treatment to support the tens of millions of additional patients with
prediabetes and obesity, as provide an on-ramp to reversal for those with T2D
that aren’t yet ready to reverse.
Virta Health, the
leader in type 2 diabetes reversal, today introduced the addition
Read More
Abbott Receives CE Mark for World’s Smallest & Thinnest Glucose Sensor in Europe
What You Should Know:
- Abbott has received CE Mark (European approval)
for its next-generation FreeStyle Libre 3 system for people with diabetes.
- FreeStyle Libre 3 is the latest advancement from
Abbott’s FreeStyle Libre family of products and featuring the smallest, thinnest
continuous glucose monitoring (CGM) sensor (~size of two stacked U.S. pennies)
and a more environmentally sustainable system design.
Abbott, the worldwide
leader in continuous glucose
Read More
Why Now’s the Time to Use Connected Health Devices for Diabetes Prevention
It’s no secret that chronic disease remains the leading cause of death worldwide, taking up 90 percent of healthcare spending in the United States. For the last several years, there has been a rise in discussions and research around the promise of connected health devices helping manage and prevent chronic conditions as well as healthcare spending. However, today a number of factors are coming together to make that promise a reality. This includes the improvement of real-world data insights
Read More
State of Connecticut Launches of Livongo for Diabetes Management Program through State Health Plan
What You Should Know:
- Connecticut state Comptroller Kevin Lembo announces the launch of Livongo for Diabetes Management Program through the state health plan to deliver estimated annual savings to the state of approximately $3 million.
- The program, launched in partnership with CVS Caremark and Livongo, is projected to significantly improve health care outcomes for thousands of people with diabetes covered by the state plan by providing them with comprehensive around-the-clock live
Read More
CDC Recognizes Lark Health’s A.I. Diabetes Prevention Program
Lark Health, a chronic disease prevention platform, today announced that its AI-based Diabetes Prevention Program (DPP) has received Full Recognition status from the Centers for Disease Control and Prevention. CDC Full Recognition is the highest level of clinical recognition for the DPP, and Lark is now the only DPP that uses cutting edge A.I. to be awarded this recognition.Lark's DPP is the second-largest in the country and one of the fastest-growing. Lark's A.I. platform is augmented by
Read More
Health2047 Spin Out Launches with $2M to Build Platform for People Living with Prediabetes
Health2047 Inc., an American Medical Association-backed company that develops and commercializes solutions to transform healthcare at the system level, today announced the spin out of First Mile Care. With $2M in seed funding, First Mile Care is a preventive chronic care startup that is building an affordable, scalable and sustainable platform to improve the lives of people who have prediabetes. Development is already underway for First Mile Care’s initial platform offering is based on the
Read More
Study: AI Mobile Platform Performs Better than CDC’s Diabetes Program
A new study in this week’s Journal of Medical Internet Research finds that a mobile platform using artificial intelligence helps diabetics and obese people better than the federal government’s National Diabetes Prevention Program. The pilot study, “Weight Loss Using a Novel Mobile Diabetes Prevention Program Delivery Platform With Human Coaching: 65-Week Observational Follow-Up,” published yesterday followed diabetics and obese people over the course of 65 weeks. Participants logged their
Read More
